Equine Rhinopneumonitis Vaccine
For intramuscular vaccination of healthy horses 9
months of age or older as an aid in the prevention of respiratory
diseases caused by the EHV 1p and EHV 1b viruses as well as for use in
pregnant mares as an aid in the prevention of abortion due to EHV 1
DOSAGE AND ADMINISTRATION: For
pregnant mares, aseptically administer one 2 mL dose intramuscularly
during the 5th, 7th and 9th months of pregnancy. Revaccinate annually
at the 5th, 7th and 9th months of pregnancy.
For young horses, aseptically administer one 2 mL dose
intramuscularly after weaning, followed by a second 2 mL dose 3 to 4
weeks later. Revaccinate with a single 2 mL dose 6 months after the
second primary dose and annually thereafter. To insure proper placement
and retention of the vaccine, inject deep into the heavy muscles of the
hindquarter. Mild exercise to promote absorption is recommended for one
week after injection.
CAUTION: Store in the dark at 2° to
7°C (35° to 45°F). AVOID FREEZING. SHAKE VIGOROUSLY to assure uniform
suspension of the vaccine. Use entire contents when first opened (20
mL). When used according to instructions, local or systemic reactions
rarely occur. An occasional local swelling or induration at the site of
injection may be encountered. Do not vaccinate within 60 days before
slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.
For Veterinary Use Only
Remove serial number and expiration date label and place on the animal’s medical chart.
© 2008, 2009 Fort Dodge Animal Health. All Rights Reserved.
Fort Dodge Animal Health, A division of Wyeth, Fort Dodge, Iowa 50501 U.S.A.
U.S. Vet. License No. 112
12 x 2 mL pre-loaded syringes
20 mL (10 doses)
10 x 20 mL (100 doses)
NAC No.: 10031465